> Articles

Asian Thoracic Oncology Research Group (ATORG) Expert Consensus Statement on MET Alterations in NSCLC: Diagnostic and Therapeutic Considerations

Ahn MJ, Mendoza MJL, Pavlakis N, Kato T, Soo RA, Kim DW, Liam CK, Hsia TC, Lee CK, Reungwetwattana T, Geater S, Chan OSH, Prasongsook N, Solomon BJ, Nguyen TTH, Kozuki T, Yang JCH, Wu YL, Mok TSK, Tan DSW, Yatabe Y. Clinical Lung Cancer,2022; 23(8):670-685. Published online December 2022,

Clinical Characteristics and Outcomes in Advanced KRAS-Mutated NSCLC: A Multicenter Collaboration in Asia (ATORG005)

Lee J, Tan AC, Zhou S, Yoon S, Liu S, Masuda K, Hayashi H, Batra U, Kim DW, Goto Y, Tan SH, Wu YL, Lee DH, Tan DSW, Ahn MJ. JTO Clin Res Rep. 2022; 3:100261. Published online: December 04, 2021,

Asian Thoracic Oncology Research Group Expert Consensus Statement on Optimal Management of Stage III Non-Small Cell Lung Cancer

Tan WL, Chua KLM, J Lin, Chan A, Ho GF, Tho LM, V Lee, Reungwetwattana T, Soo R, Yang JCY, Kim DW, Ahn YC, Onishi H, Ahn MJ, Mok TS, Tan DS, Yang F. J Thorac Oncol, 2019 Nov 13. Pii: S1556-0864(19)33640-8. Published online: November 13, 2019,

> Poster Presentation

362P Intracranial activity of dacomitinib in treatment naïve advanced EGFR mutated non-small cell lung cancer (NSCLC): Prespecified subgroup analysis of the ATORG-003 trial

Tan AC, Kim DW, (Baisamut) Reungwetwattana T, Yueh Ni L, Ho GF, Tho LM, Prasongsook N, Lee S, Mok TSK, Tan DSW, Loong HHF.Annals of Oncology, 2022; 33(9)S1582-S1583. Published online: November 01, 2022,

Molecular profiling of non-small cell lung cancer (NSCLC) in Asia with targeted next-generation sequencing (NGS): Interim analysis of a co-operative group study (ATORG001)

Tan AC, Loong H, Ho GF, Seet A, Chiam B, Cheah DQ, Tan GS, Lim KH, Yang JCH, Mok TSK, Kim DW, Tan DSW.Annals of Oncology, 2019; 30:IX126. Published online: November 01, 2019,